Overview

Anti-Androgen Treatment for COVID-19

Status:
Completed
Trial end date:
2021-01-21
Target enrollment:
Participant gender:
Summary
This study is intended to explore the possible protective role of anti-androgens in SARS-CoV-2 infection
Phase:
N/A
Details
Lead Sponsor:
Applied Biology, Inc.
Treatments:
Azithromycin
Dutasteride
Ivermectin